← Back to Screener
US Stock Screener
HomeScreensNewsWatchlist
...

Addus HomeCare Corporation (ADUS) 10-Year Financial Performance & Capital Metrics

ADUS • • Industrial / General
HealthcareHealthcare FacilitiesHome Health & Hospice CarePersonal Care & Support Services
AboutAddus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. It operates through three segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living. This segment offers services that include assistance with bathing, grooming, oral care, feeding and dressing, medication reminders, meal planning and preparation, housekeeping, and transportation services. The Hospice segment provides palliative nursing care, social work, spiritual counseling, homemaker, and bereavement counseling services for people who are terminally ill, as well as related services for their families. The Home Health segment offers skilled nursing and physical, occupational, and speech therapy for the individuals who requires assistance during an illness or after hospitalization. The company's payor clients include federal, state, and local governmental agencies; managed care organizations; commercial insurers; and private individuals. As of December 31, 2021, the company served consumers through 206 offices located in 22 states. Addus HomeCare Corporation was founded in 1979 and is based in Frisco, Texas.Show more
  • Revenue $1.15B +9.1%
  • EBITDA $116M +10.6%
  • Net Income $74M +17.7%
  • EPS (Diluted) 4.23 +10.4%
  • Gross Margin 32.48% +1.2%
  • EBITDA Margin 10.07% +1.4%
  • Operating Margin 8.89% +3.5%
  • Net Margin 6.37% +7.9%
  • ROE 8.78% -5.9%
  • ROIC 7.85% -10.9%
  • Debt/Equity 0.28 +13.5%
  • Interest Coverage 13.28 +62.2%
Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

  • ✓Strong 5Y profit CAGR of 23.9%
  • ✓High quality earnings: Operating CF exceeds net income
  • ✓Strong 5Y sales CAGR of 12.2%

✗Weaknesses

No significant weaknesses identified

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y13.95%
5Y12.22%
3Y10.13%
TTM18.77%

Profit (Net Income) CAGR

10Y19.65%
5Y23.87%
3Y17.71%
TTM16.3%

EPS CAGR

10Y14.42%
5Y19.03%
3Y14.61%
TTM6.87%

ROCE

10Y Avg9.44%
5Y Avg8.8%
3Y Avg9.6%
Latest9.61%

Peer Comparison

Personal Care & Support Services
Select Columns
Size & Scale
Valuation
Per Share
Growth
Profitability
Quality & Returns
Safety & Leverage
TTM Growth
Famous Investor Metrics
Dividends
Latest Quarter
Momentum & Returns
Total Return (DRIP)
Technical
Volume & Trading
Shares & Dilution
Sector-Specific
NameMarket CapCurrent PriceP/E RatioRevenue Growth 1YNet MarginROEFCF YieldDebt/Equity
ADUSAddus HomeCare Corporation2.03B109.8025.969.06%6.36%8.16%5.44%0.28

Profit & Loss

Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024
Sales/Revenue+336.81M400.69M425.71M518.12M648.79M764.77M864.5M951.12M1.06B1.15B
Revenue Growth %0.08%0.19%0.06%0.22%0.25%0.18%0.13%0.1%0.11%0.09%
Cost of Goods Sold+245.49M294.59M310.12M379.84M469.55M538.54M595.24M651.38M718.77M779.58M
COGS % of Revenue0.73%0.74%0.73%0.73%0.72%0.7%0.69%0.68%0.68%0.68%
Gross Profit+91.32M106.09M115.6M138.28M179.24M226.24M269.85M299.74M339.88M375.02M
Gross Margin %0.27%0.26%0.27%0.27%0.28%0.3%0.31%0.32%0.32%0.32%
Gross Profit Growth %0.09%0.16%0.09%0.2%0.3%0.26%0.19%0.11%0.13%0.1%
Operating Expenses+75.3M90.86M91.82M113.94M144.49M181.73M203.32M231M248.92M272.33M
OpEx % of Revenue0.22%0.23%0.22%0.22%0.22%0.24%0.24%0.24%0.24%0.24%
Selling, General & Admin70.58M84.21M76.9M105.03M133.57M169.68M189.42M216.94M231.68M258.8M
SG&A % of Revenue0.21%0.21%0.18%0.2%0.21%0.22%0.22%0.23%0.22%0.22%
Research & Development0000000000
R&D % of Revenue----------
Other Operating Expenses4.72M6.65M14.92M8.91M10.92M12.05M13.9M14.06M17.24M13.53M
Operating Income+16.02M15.48M25.25M22.83M34.75M44.51M65.94M68.74M90.96M102.69M
Operating Margin %0.05%0.04%0.06%0.04%0.05%0.06%0.08%0.07%0.09%0.09%
Operating Income Growth %-0.11%-0.03%0.63%-0.1%0.52%0.28%0.48%0.04%0.32%0.13%
EBITDA+20.74M22.12M31.92M31.47M45.33M56.56M80.43M82.8M105.08M116.22M
EBITDA Margin %0.06%0.06%0.07%0.06%0.07%0.07%0.09%0.09%0.1%0.1%
EBITDA Growth %-0.05%0.07%0.44%-0.01%0.44%0.25%0.42%0.03%0.27%0.11%
D&A (Non-Cash Add-back)4.72M6.65M6.66M8.64M10.57M12.05M14.49M14.06M14.13M13.53M
EBIT16.07M18.25M26.65M25.42M36.27M45.13M66.2M69.08M92.43M107.08M
Net Interest Income+-739K480K-4.41M-2.42M-1.58M-2.56M-5.54M-8.57M-9.63M-3.34M
Interest Income47K2.81M66K2.59M1.52M624K268K341K1.48M4.39M
Interest Expense786K2.33M4.47M5.02M3.1M3.19M5.81M8.91M11.11M7.73M
Other Income/Expense-739K686K-5.17M-2.42M-1.58M-2.56M-5.54M-8.57M-9.63M-3.34M
Pretax Income+15.29M16.16M21.06M20.4M33.17M41.94M60.4M60.17M81.33M99.35M
Pretax Margin %0.05%0.04%0.05%0.04%0.05%0.05%0.07%0.06%0.08%0.09%
Income Tax+3.93M4.1M9.26M4.1M7.36M8.81M15.27M14.15M18.81M25.75M
Effective Tax Rate %0.76%0.74%0.65%0.86%0.76%0.79%0.75%0.76%0.77%0.74%
Net Income+11.62M12.02M13.61M17.5M25.24M33.13M45.13M46.02M62.52M73.6M
Net Margin %0.03%0.03%0.03%0.03%0.04%0.04%0.05%0.05%0.06%0.06%
Net Income Growth %-0.05%0.03%0.13%0.29%0.44%0.31%0.36%0.02%0.36%0.18%
Net Income (Continuing)11.35M12.06M13.53M16.31M25.81M33.13M45.13M46.02M62.52M73.6M
Discontinued Operations270K97K147K126K000000
Minority Interest0000000000
EPS (Diluted)+1.041.041.171.331.772.082.812.843.834.23
EPS Growth %-0.05%0%0.13%0.14%0.33%0.18%0.35%0.01%0.35%0.1%
EPS (Basic)1.051.041.171.331.832.122.872.903.914.33
Diluted Shares Outstanding11.19M11.53M11.63M13.13M14.25M15.96M16.06M16.18M16.31M17.38M
Basic Shares Outstanding11.11M11.29M11.47M13.13M13.82M15.83M15.74M16.13M16.23M17.01M
Dividend Payout Ratio----------

Balance Sheet

Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024
Total Current Assets+102.56M131.01M155.67M176.01M269.39M287.7M324.34M222.81M200M260.38M
Cash & Short-Term Investments4.1M8.01M53.75M70.41M111.71M145.08M168.9M79.96M64.79M98.91M
Cash Only4.1M8.01M53.75M70.41M111.71M145.08M168.9M79.96M64.79M98.91M
Short-Term Investments0000000000
Accounts Receivable86.26M117.75M93.53M100.57M153.24M134.51M146.07M126.17M116.08M135.26M
Days Sales Outstanding93.48107.2680.1970.8586.2164.261.6748.4240.0242.76
Inventory8.64M000000000
Days Inventory Outstanding12.85---------
Other Current Assets2.49M1.82M4.7M5.04M2.4M2.18M2.49M5.39M2.23M7.83M
Total Non-Current Assets+90.05M100.02M116.03M169.88M367.36M604.88M623.24M715.19M824.42M1.15B
Property, Plant & Equipment8.62M6.65M7.49M10.66M33.27M57.74M54.53M60.16M69.44M72.05M
Fixed Asset Turnover39.08x60.27x56.85x48.61x19.50x13.25x15.85x15.81x15.24x16.02x
Goodwill68.84M73.91M90.34M135.44M275.37M469.07M504.39M582.84M663M970.56M
Intangible Assets10.35M15.41M16.6M23.78M57.08M71.55M64.32M72.19M91.98M109.64M
Long-Term Investments900K900K-1.6M0000000
Other Non-Current Assets-10.18M01.6M43K000000
Total Assets+192.61M231.03M267.11M355.39M636.75M892.58M947.59M937.99M1.02B1.41B
Asset Turnover1.75x1.73x1.59x1.46x1.02x0.86x0.91x1.01x1.03x0.82x
Asset Growth %0.07%0.2%0.16%0.33%0.79%0.4%0.06%-0.01%0.09%0.38%
Total Current Liabilities+42.19M49.62M52.17M61.5M87.53M143.9M117.69M131.15M145.12M155.87M
Accounts Payable4.75M4.49M7.38M12.24M19.64M23.7M19.36M22.09M26.18M27.18M
Days Payables Outstanding7.065.568.6911.7615.2716.0711.8712.3813.312.72
Short-Term Debt1.11M2.53M3.1M62K728K971K9.77M000
Deferred Revenue (Current)1000K1000K1000K769K01000K1000K1000K1000K1000K
Other Current Liabilities-18.96M-16K-1.06M-769K14.14M17.96M19.79M17.37M30.38M13.64M
Current Ratio2.43x2.64x2.98x2.86x3.08x2.00x2.76x1.70x1.38x1.67x
Quick Ratio2.23x2.64x2.98x2.86x3.08x2.00x2.76x1.70x1.38x1.67x
Cash Conversion Cycle99.27---------
Total Non-Current Liabilities+8.7M22.48M39.86M18.1M73.63M230M255.55M173.31M172.62M286.27M
Long-Term Debt1.88M22.48M39.86M17.22M59.16M193.9M220.91M131.77M124.13M218.44M
Capital Lease Obligations000014.3M35.52M32.86M35.48M39.71M41.88M
Deferred Tax Liabilities6.82M08.41M00000025.82M
Other Non-Current Liabilities-6.82M0446K877K163K588K1.78M6.06M8.77M125K
Total Liabilities50.89M72.1M92.03M79.86M161.16M373.91M373.24M304.45M317.73M442.14M
Total Debt+2.99M25.01M42.96M17.28M81.43M239.67M263.55M178.05M175.18M273.13M
Net Debt-1.11M17M-10.79M-53.12M-30.29M94.59M94.65M98.09M110.39M174.22M
Debt / Equity0.02x0.16x0.25x0.06x0.17x0.46x0.46x0.28x0.25x0.28x
Debt / EBITDA0.14x1.13x1.35x0.55x1.80x4.24x3.28x2.15x1.67x2.35x
Net Debt / EBITDA-0.05x0.77x-0.34x-1.69x-0.67x1.67x1.18x1.18x1.05x1.50x
Interest Coverage20.39x6.64x5.65x4.55x11.19x13.96x11.36x7.72x8.19x13.28x
Total Equity+141.73M158.93M175.08M275.53M475.59M518.68M574.34M633.54M706.69M970.49M
Equity Growth %0.11%0.12%0.1%0.57%0.73%0.09%0.11%0.1%0.12%0.37%
Book Value per Share12.6713.7915.0520.9933.3832.5135.7539.1543.3355.84
Total Shareholders' Equity141.73M158.93M176.31M275.53M475.59M518.68M574.34M633.54M706.69M970.49M
Common Stock11K12K12K13K15K16K16K16K16K18K
Retained Earnings54.64M66.66M80.33M97.84M116.03M149.16M194.29M240.32M302.83M376.43M
Treasury Stock0000000000
Accumulated OCI00-4.84M0000000
Minority Interest0000000000

Cash Flow

Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024
Cash from Operations+4.11M-743K52.77M33.2M12.02M109.41M39.49M105.11M112.25M116.43M
Operating CF Margin %0.01%-0%0.12%0.06%0.02%0.14%0.05%0.11%0.11%0.1%
Operating CF Growth %-0.42%-1.18%72.02%-0.37%-0.64%8.1%-0.64%1.66%0.07%0.04%
Net Income11.62M12.02M13.61M17.5M25.24M33.13M45.13M46.02M62.52M73.6M
Depreciation & Amortization4.72M6.65M6.66M8.64M10.57M12.05M14.49M14.06M14.13M13.53M
Stock-Based Compensation1.57M1.07M2.55M4.11M5.77M6M9.43M10.63M10.32M11.16M
Deferred Taxes838K-1.33M1.75M-43K-1.06M-4.65M7.28M3.91M2.82M13.19M
Other Non-Cash Items4.54M10.28M8.04M69K1.06M2.91M1.77M2.71M1.58M3.44M
Working Capital Changes-19.18M-29.44M20.15M2.92M-29.55M59.96M-38.61M27.78M20.89M1.51M
Change in Receivables-19.51M-32.61M21.02M-2.17M-37.48M23.86M-3.92M20.59M15.67M22.14M
Change in Inventory-60.61M-76.69M-99.56M-123.14M00-1.97M000
Change in Payables570K-1.53M-229K4.24M4.64M2.16M-4.81M2.51M2.02M-1.91M
Cash from Investing+-10.72M-21.74M-24.27M-67.79M-188.7M-214.24M-42.02M-106.59M-119.24M-354.61M
Capital Expenditures-2.36M-1.71M-3.62M-5.35M-4.62M-6.83M-4.64M-8.3M-9.45M-6.05M
CapEx % of Revenue0.01%0%0.01%0.01%0.01%0.01%0.01%0.01%0.01%0.01%
Acquisitions----------
Investments----------
Other Investing-10.72M-21.74M3.7M0000015K29K
Cash from Financing+-2.64M26.39M17.24M51.24M217.99M138.19M26.34M-87.45M-8.18M272.3M
Debt Issued (Net)----------
Equity Issued (Net)----------
Dividends Paid0000000000
Share Repurchases----------
Other Financing-1.59M3.5M-1.7M71K2.78M0-3.03M0049K
Net Change in Cash----------
Free Cash Flow+1.75M-2.46M49.16M27.85M7.4M102.58M34.84M96.81M102.79M110.38M
FCF Margin %0.01%-0.01%0.12%0.05%0.01%0.13%0.04%0.1%0.1%0.1%
FCF Growth %2.08%-2.41%21.02%-0.43%-0.73%12.87%-0.66%1.78%0.06%0.07%
FCF per Share0.16-0.214.232.120.526.432.175.986.306.35
FCF Conversion (FCF/Net Income)0.35x-0.06x3.88x1.90x0.48x3.30x0.88x2.28x1.80x1.58x
Interest Paid786K2.32M2.26M4.34M2.32M2.37M5.09M7.99M10.25M6.52M
Taxes Paid911K5.09M6.72M4.1M7.3M10.59M17.82M1.48M14.98M26.25M

Key Ratios

Metric2015201620172018201920202021202220232024
Return on Equity (ROE)8.62%8%8.15%7.77%6.72%6.66%8.26%7.62%9.33%8.78%
Return on Invested Capital (ROIC)9.29%7.33%11.13%8.85%7.81%6.31%7.71%7.36%8.81%7.85%
Gross Margin27.11%26.48%27.15%26.69%27.63%29.58%31.21%31.51%32.1%32.48%
Net Margin3.45%3%3.2%3.38%3.89%4.33%5.22%4.84%5.91%6.37%
Debt / Equity0.02x0.16x0.25x0.06x0.17x0.46x0.46x0.28x0.25x0.28x
Interest Coverage20.39x6.64x5.65x4.55x11.19x13.96x11.36x7.72x8.19x13.28x
FCF Conversion0.35x-0.06x3.88x1.90x0.48x3.30x0.88x2.28x1.80x1.58x
Revenue Growth7.63%18.96%6.25%21.71%25.22%17.88%13.04%10.02%11.31%9.06%

Revenue by Segment

2018201920202021202220232024
Personal Care65.12M108.4M115.51M99.73M86.59M794.72M856.58M
Personal Care Growth-66.47%6.56%-13.66%-13.18%817.77%7.78%
Hospice18.85M38.79M42.65M61.41M70.5M207.16M228.19M
Hospice Growth-105.78%9.95%44.00%14.80%193.82%10.15%
Home Health6.86M14.46M16.25M24.73M34.11M56.78M69.83M
Home Health Growth-110.94%12.33%52.26%37.91%66.45%22.98%

Frequently Asked Questions

Valuation & Price

Addus HomeCare Corporation (ADUS) has a price-to-earnings (P/E) ratio of 26.0x. This suggests investors expect higher future growth.

Growth & Financials

Addus HomeCare Corporation (ADUS) reported $1.35B in revenue for fiscal year 2024. This represents a 393% increase from $273.1M in 2011.

Addus HomeCare Corporation (ADUS) grew revenue by 9.1% over the past year. This is steady growth.

Yes, Addus HomeCare Corporation (ADUS) is profitable, generating $85.7M in net income for fiscal year 2024 (6.4% net margin).

Dividend & Returns

Addus HomeCare Corporation (ADUS) has a return on equity (ROE) of 8.8%. This is below average, suggesting room for improvement.

Addus HomeCare Corporation (ADUS) generated $99.6M in free cash flow for fiscal year 2024. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

VCP Scanner

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screens
  • Valuation
  • Compare
  • Total Return
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Twitter
  • Get Early Access
© 2026 VCP Scanner. All rights reserved.
Made with ❤️ for investors
Not financial advice. Do your own research.